# Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)

> **NCT00383240** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 781 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
- **DRUG:** Mometasone furoate MDI (MF MDI) 200 mcg
- **DRUG:** formoterol fumarate 10 mcg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00383240
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 781 (ACTUAL)
- **Last updated:** 2024-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383240, "Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00383240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*